![John Orwin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Orwin
Président chez
ANAPTYSBIO, INC.
Fortune : 4 M $ au 30/06/2026
Profil
John A. Orwin is the founder of Ambrosia Biosciences, Inc. Current positions include Chairman at AnaptysBio, Inc. since 2023, Chairman at First Tracks Biotherapeutics, Inc., Director at Biotechnology Innovation Organization, Independent Director at Travere Therapeutics, Inc. since 2017, and Venture Partner at Samsara BioCapital LLC starting in 2024.
Former roles include Chief Executive Officer at Relypsa, Inc. in 2017, President, CEO, CFO & Director at Atreca, Inc. from 2023 to 2024, Chairman at Affymax, Inc. from 2013 to 2014, Chairman at Cargo Therapeutics, Inc. from 2022 to 2025, Chairman at Nested Therapeutics, Inc., Marketing Director-Oncology Division at ALZA Corp., Independent Director at Array BioPharma, Inc. from 2012 to 2019, Independent Director at NeurogesX, Inc. from 2011 to 2013, Marketing Director at Rhone-Poulenc Rorer Pharmaceuticals, Inc. in 1998, Independent Director at Seagen, Inc. from 2014 to 2023, Senior Vice President-BioOncology Business Unit at Genentech, Inc. from 2005 to 2010, Franchise Vice President-Oncology at Johnson & Johnson from 2001 to 2005, Product Manager-Oncology Division at Schering-Plough Corp.
in 1994, Vice President-Marketing at SangStat Medical Corp.
in 2000, Trustee at Cancer Care, Inc., and Vice President-Oncology Franchise at Janssen Biotech, Inc. in 2004.
Education includes an MBA from New York University, an undergraduate degree from Rutgers State University of New Jersey in 1987, and an MBA from The Leonard N Stern School of Business in 1996.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/05/2026 | 39 375 ( 0,04 % ) | 2 M $ | 30/06/2026 | |
ANAPTYSBIO, INC. 0,06 % | 15/06/2026 | 16 695 ( 0,06 % ) | 1 M $ | 30/06/2026 |
0,05 % | 15/06/2026 | 16 695 ( 0,05 % ) | 335 903 $ | 30/06/2026 |
Postes actifs de John Orwin
| Sociétés | Poste | Début |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 23/03/2017 |
| ANAPTYSBIO, INC. | Président | 15/09/2023 |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Private Equity Investor | 01/06/2024 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | - |
Anciens postes connus de John Orwin
| Sociétés | Poste | Fin |
|---|---|---|
| CARO THERPAR | Président | 19/08/2025 |
| SEAGEN INC. | Directeur/Membre du Conseil | 01/12/2023 |
| ARRAY TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 30/07/2019 |
| RELYPSA INC | Directeur Général | 01/06/2017 |
| AFFYMAX, INC. | Directeur Général | 06/06/2013 |
Formation de John Orwin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
23
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 23 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
SangStat Medical Corp.
 SangStat Medical Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic and monitoring products to improve the outcome of organ transplantation | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Atreca, Inc.
 Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeurogesX, Inc.
 NeurogesX, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pain management therapies | Health Technology |
Cancer Care, Inc.
 Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
Janssen Biotech, Inc.
 Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Finance |
Cargo Therapeutics, Inc.
 Cargo Therapeutics, Inc. BiotechnologyHealth Technology Engages in generation of adoptive cell therapies for cancer treatment | Health Technology |
Nested Therapeutics, Inc.
 Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery biotechnology company | Commercial Services |
